StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MLOCT.PA$0.22+1.85%
Fair $0.22+0.0%

MLOCT.PA

Octopus Biosafety SA

Technology / Computer HardwareParis

$0.22

+0.00 (+1.85%)

Fairly Valued+0.0%Fair Value $0.22Fund rank 32/100 · Data gapFallback financials|
SA 34/D
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF n/d · quality 66.0/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 50/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

34/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 1.0%, below the 5% threshold
Thesis & Journal · MLOCT.PALocal privado en este navegador · Octopus Biosafety SA
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$28M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

100.5%

↑

Gross Margin

-642.9%

↓

Debt/Equity

-0.83

↓
52-Week Range$0
$0$1

TradingView lightweight chart

MLOCT.PA price, volumen y niveles de valoración

Último $0.220Periodo -98.2%
Fair value: $0.220

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

-7.8%

FCF CAGR

—

FCF margin

—

FCF / Net income

—

Latest source

Provider fallback

Margin decomposition

Último año: revenue $52308.0 · net income $-659106.0 · FCF —

2021-FY → 2024-FY

Gross margin

-642.9%-724.9% pts

Operating margin

-1029.5%+621.3% pts

Net margin

-1260.0%+252.4% pts

FCF margin

—— pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$52308.00$52308.00$229348.00$21801.00$66817.00
Net Income$-659106.00$-659106.00$-1.8M$-802728.00$-1.0M
EBITDA$-837482.00$-837482.00$-1.2M$-485717.00$-626637.00
EPS——-0.12-0.20-0.25
Gross Margin-642.9%-642.9%-30.5%-252.9%82.0%
Operating Margin-1029.5%-1029.5%-344.8%-3305.0%-1650.9%
Net Margin-1260.0%-1260.0%-774.8%-3682.1%-1512.4%
Balance Sheet
Debt/Equity-0.83-0.83112.57-1.87-2.71
Current Ratio0.320.32———
Returns
ROE100.5%100.5%-56612.5%55.8%158.9%
Valuation
P/B——1036.15——
Growth & Yield
Revenue Growth-77.2%-77.2%952.0%-67.4%—
EPS Growth——39.3%20.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +96.4%

Total return

+96.4%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.12 → n/d

Residual

+96.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+96.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.